GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Bax | increases expression | EXP | | 6480464 | CTD | pyrazolanthrone results in increased expression of BAX protein | PMID:16046226 PMID:19428505 | Bax | multiple interactions | EXP | | 6480464 | CTD | pyrazolanthrone inhibits the reaction [bakuchiol affects the localization of BAX protein]; pyrazolanthrone inhibits the reaction [cadmium acetate results in increased expression of BAX protein]; pyrazolanthrone inhibits the reaction [IL1B protein results in increased expression of BAX protein]; pyrazolanthrone inhibits the reaction [Isoflurane results in increased expression of BAX protein]; pyrazolanthrone inhibits the reaction [sodium arsenite results in increased expression of BAX protein] | PMID:14514659 PMID:17292878 PMID:24577723 PMID:25043952 PMID:29289695 PMID:35172196 | Bax | increases expression | ISO | BAX (Homo sapiens) | 6480464 | CTD | pyrazolanthrone results in increased expression of BAX protein | PMID:15034932 | Bax | multiple interactions | ISO | Bax (Mus musculus) | 6480464 | CTD | pyrazolanthrone inhibits the reaction [Acetaminophen affects the localization of BAX protein]; pyrazolanthrone inhibits the reaction [triethylene glycol dimethacrylate results in increased expression of BAX protein] | PMID:20423716 PMID:33684387 | Bax | multiple interactions | ISO | BAX (Homo sapiens) | 6480464 | CTD | [U 0126 co-treated with pyrazolanthrone] inhibits the reaction [fisetin results in increased expression of BAX protein]; [XMU-MP-1 co-treated with U 0126 co-treated with pyrazolanthrone] inhibits the reaction [fisetin results in increased expression of BAX protein]; MYC affects the reaction [pyrazolanthrone results in increased expression of BAX protein]; pyrazolanthrone affects the reaction [Methylmercury Compounds affects the localization of BAX protein]; pyrazolanthrone inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased expression of BAX protein]; pyrazolanthrone inhibits the reaction [4-vinyl-2,6-dimethoxyphenol results in increased expression of BAX protein]; pyrazolanthrone inhibits the reaction [Acetaminophen results in increased expression of BAX protein]; pyrazolanthrone inhibits the reaction [Arachidonic Acid affects the localization of BAX protein]; pyrazolanthrone inhibits the reaction [Docetaxel results in increased activity of BAX protein]; pyrazolanthrone inhibits the reaction [fisetin results in increased expression of BAX protein]; pyrazolanthrone inhibits the reaction [Methylmercury Compounds inhibits the reaction [BAX protein binds to YWHAZ protein]]; pyrazolanthrone inhibits the reaction [nickel sulfate results in increased expression of BAX protein]; pyrazolanthrone inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) affects the localization of BAX protein]; pyrazolanthrone inhibits the reaction [surfactin peptide results in increased expression of BAX protein]; pyrazolanthrone promotes the reaction [Arsenic Trioxide results in increased activity of and results in increased localization of BAX protein] | PMID:15034932 PMID:16972261 PMID:17317842 PMID:19540902 PMID:19954742 PMID:21420390 PMID:24036456 PMID:30653946 PMID:31044527 PMID:33959992 PMID:34999165 PMID:35499276 | |
Go Back to source page | Continue to Ontology report |